Publicaciones en colaboración con investigadores/as de Hospital Universitario Príncipe de Asturias (30)

2024

  1. Corrigendum to: “Changes in the immune response against SARS-CoV-2 in individuals with severe COVID-19 treated with high dose of vitamin D” [Biomed. Pharmacother. 150 (2022) 1−11] (Biomedicine & Pharmacotherapy (2022) 150, (S0753332222003547), (10.1016/j.biopha.2022.112965))

    Biomedicine and Pharmacotherapy

2023

  1. Impact of the COVID 19 pandemic on new diagnoses of HIV infection

    Medicina Clinica, Vol. 160, Núm. 3, pp. 133-134

2022

  1. Changes in the immune response against SARS-CoV-2 in individuals with severe COVID-19 treated with high dose of vitamin D

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, Vol. 150, pp. 112965

2021

  1. A predictive model and risk factors for case fatality of covid-19

    Journal of Personalized Medicine, Vol. 11, Núm. 1, pp. 1-18

  2. COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study

    HIV Medicine, Vol. 22, Núm. 9, pp. 867-876

  3. Impact of Remdesivir on the Treatment of COVID-19 During the First Wave in Spain

    Advances in Therapy, Vol. 38, Núm. 7, pp. 4057-4069

  4. Medical prognosis of infectious diseases in nursing homes by applying machine learning on clinical data collected in cloud microservices

    International Journal of Environmental Research and Public Health, Vol. 18, Núm. 24

2020

  1. Predicting Infectious Diseases by Using Machine Learning Classifiers

    Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics)

  2. Reply to “How to limit bias in quasiexperimental studies”

    Enfermedades Infecciosas y Microbiologia Clinica

  3. mHealth System for the Early Detection of Infectious Diseases Using Biomedical Signals

    Lecture Notes in Networks and Systems (Springer), pp. 203-213

2019

  1. Development of ehealth applications-based on microservices in a cloud architecture

    RISTI - Revista Iberica de Sistemas e Tecnologias de Informacao, Vol. 2019, Núm. E23, pp. 81-93

  2. Drug-related and psychopathological symptoms in HIV-positive men who have sex with men who inject drugs during sex (slamsex): Data from the U-SEX GESIda 9416 study

    PLoS ONE, Vol. 14, Núm. 12

  3. Dual prophylaxis with teicoplanin and cefazolin in the prevention of prosthetic joint infection

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 37, Núm. 9, pp. 588-591

  4. Executive summary of the GeSIDA/National AIDS Plan consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2018)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 37, Núm. 3, pp. 195-202

2018

  1. Increased indoleamine-2,3-dioxygenase activity is associated with poor clinical outcome in adults hospitalized with influenza in the INSIGHT FLU003Plus study

    Open Forum Infectious Diseases, Vol. 5, Núm. 1

2017

  1. Simplification to dual therapy (atazanavir/ritonavir1lamivudine) versus standard triple therapy [atazanavir/ritonavir1two nucleos(t)ides] in virologically stable patients on antiretroviral therapy: 96 week results from an open-label, non-inferiority, randomized clinical trial (SALT study)

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 1, pp. 246-253

2015

  1. Dual treatment with atazanavir-ritonavir plus lamivudine versus triple treatment with atazanavir-ritonavir plus two nucleos(t)ides in virologically stable patients with HIV-1 (SALT): 48 week results from a randomised, open-label, non-inferiority trial

    The Lancet Infectious Diseases, Vol. 15, Núm. 7, pp. 775-784

2014

  1. Reducing major lower extremity amputations after the introduction of a multidisciplinary team for the diabetic foot

    International Journal of Lower Extremity Wounds, Vol. 13, Núm. 1, pp. 22-26

2010

  1. Minimal removal of raltegravir by hemodialysis in HIV-infected patients with end-stage renal disease

    Antimicrobial Agents and Chemotherapy, Vol. 54, Núm. 7, pp. 3047-3048

  2. Protocolo de diagnóstico diferencial de las faringoamigdalitis

    Medicine, Vol. 10, Núm. 58, pp. 4015-4018